【Trend Insight】INTERPHEX Osaka: Next-Gen Pharma & DX

INTERPHEX Week Osaka is one of Japan’s leading pharmaceutical exhibitions and one of the largest pharma R&D and manufacturing technology shows in Asia. It is held annually at INTEX Osaka, organized by RX Japan Ltd., with support from major pharmaceutical associations in Japan.

The exhibition covers the entire pharmaceutical process, focusing on R&D, manufacturing equipment, laboratory instruments, packaging, contract services (CRO/CMO), automation, and digital solutions.
It consists of several specialized shows, including INTERPHEX JAPAN (Manufacturing & Packaging), in-Pharma Japan (Pharmaceutical Ingredients), BioPharma Expo (Biopharmaceuticals), and Pharma R&D Japan (Drug Discovery).

INTERPHEX Week Osaka attracts more than 1,800 exhibitors and 80,000 professional visitors from around the world every year, serving as a major platform for showcasing advanced technologies, building business networks, and facilitating industry exchange. Numerous technical conferences and seminars are also held during the event, enabling participants to stay updated on the latest trends and innovations.

Osaka is Japan’s largest pharmaceutical industry cluster and home to many leading pharmaceutical companies, making this event a critical gateway for companies seeking to enter the Japanese and broader Asian markets.

More

More Articles

Synergizing Software and Hardware Capabilities: Driving AI × GMP × Digital Twin to Accelerate the Implementation of Smart Manufacturing in Biopharmaceuticals TherapiAI, an AI-driven pharmaceutical technology company, announced yesterday (the

Continue Reading

Google and Japan’s Chiral Share the Stage to Co-Envision the Next Decade of Biopharma TherapiAI, a pioneering biotech AI startup, hosted the “AI-Driven Future of Biopharma: From R&D Innovation to

Continue Reading

TherapiAI, a leading force in AI-driven drug discovery, officially announced today (the 22nd) its strategic expansion into the Japanese market through a formal partnership with Chiral, an emerging Japanese AI

Continue Reading

Cracking the ‘Black Box’ of Cell Manufacturing for the First Time ! TherapiAI, a leading AI-powered biopharmaceutical innovator, today announced its latest research collaboration with Dr. Kun-Yi Lin, a prominent

Continue Reading

Scroll to Top